Trending Now
The US FDA Reclassifies Eyenovia Inc.’s (NASDAQ: EYEN) MyCombi Formulation As...
Eyenovia Inc. (NASDAQ: EYEN) has announced the reclassification of its novel first-in-class microdose formulation combination of phenylephrine and tropicamide for in-office pupil dilation, MydCombi,...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Titan Pharmaceuticals Inc.’s (NASDAQ:TTNP) Partner Enters Exclusive Commercialization agreement For Probuphine...
Titan Pharmaceuticals Inc. (NASDAQ:TTNP) has announced that it's Molteni Farmaceutici partner has signed an exclusive commercialization agreement with Accord Healthcare for Sixmo®, which is...
MAKE IT MODERN
LATEST REVIEWS
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Says the ZENITH20 Phase 2 Clinical Trial...
The evaluation of poziotinib in the ZENITH20 Phase 2 clinical trial has accomplished the pre-specified primary endpoint. According to Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI), which...
MAKE IT MODERN
PERFORMANCE TRAINING
Chemomab Therapeutics Ltd. (NASDAQ: CMMB) Announces Findings Supporting Use of CM-101 as A Systemic...
Chemomab Therapeutics Ltd. (NASDAQ: CMMB) has reported two scientific presentations, including patient and preclinical findings supporting the possible use of its lead treatment candidate,...
Jazz Pharmaceuticals Plc (NASDAQ: JAZZ) Finalizes Supplemental Biologics License Application Submission for Rylaze 
Jazz Pharmaceuticals Plc (NASDAQ: JAZZ) has announced that it has finalized the submission of a supplemental Biologics License Application to the US FDA for...
Merck and Co Inc. (NYSE: MRK) Plans To Acquired Acceleron Pharma Inc. (NASDAQ: XLRN)...
Merck and Co Inc. (NYSE: MRK) is in advanced negotiations to purchase Acceleron Pharma Inc. (NASDAQ: XLRN) in a move that will...
B2 Digital (BTDG) in Focus as Live Sports Stocks Present Opportunity (EDR, DKNG, WWE,...
The market has been discounting a major slowdown in the global economy based on central banks having fallen well behind the curve on inflation...
uniQure NV (NASDAQ:QURE) Enters licensing And Commercialization Deal With CSL Behring For Etranacogene Dezaparvovec
uniQure NV (NASDAQ:QURE) has announced that it has entered a licensing agreement with CSL Behring. The agreement offers CSL Behring exclusive rights globally to...
MAKE IT MODERN
